Abstracts tagged "psoriatic arthritis and patient outcomes"

Abstract Number: 2508 • 2019 ACR/ARP Annual Meeting
Large Joint and Lower Extremity Involvement Has Higher Impact on Disease Outcomes in Oligoarticular PsA
Gizem Ayan¹, Dilek Solmaz ², Sibel Bakirci ³, Ilaria Tinazzi ⁴, Ahmet Omma ⁵, Orhan Küçükşahin ⁶, Cem Ozisler ⁷, Sule Yavuz ⁸, Ozun Bayindir ⁹, Gezmiş Kimyon ¹⁰, Atalay Dogru ¹¹, Emine Figen Tarhan ¹², Meryem Can ¹³, Levent Kilic ¹⁴, Mehmet Tuncay Duruoz ¹⁵, Kenan Aksu ¹⁶, Umut Kalyoncu ¹⁷ and Sibel Zehra Aydin ¹⁸, ¹University of Ottawa Faculty of Medicine, Rheumatology, Ottawa, ON, Canada, ²Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İzmir, Turkey, ³Antalya Education and Research Hospital, Antalya, Turkey, ⁴Sacro Cuore Don Calabria Hospital, Unit of Rheumatology, Verona, Italy, ⁵Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, ⁶Liv Hospital, Ankara, Turkey, ⁷Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, ⁸Uppsala University, Istanbul, Turkey, ⁹Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey, ¹⁰Mustafa Kemal University, Hatay, Turkey, ¹¹Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey, ¹²Mugla Sitki Kocman University, Department of Internal Medicine, Division of Rheumatology Mugla,, Mugla, Turkey, ¹³Marmara University, Division of Rheumatology, Istanbul, Turkey, Istanbul, Turkey, ¹⁴Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, ¹⁵Marmara University School of Medicine, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Istanbul, Turkey, ¹⁶Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, ¹⁷Hacettepe University Department of Rheumatology, Ankara, Turkey, ¹⁸University of Ottawa Faculty of Medicine, Rheumatology,Ottawa Hospital Research Institute, 1967 Riverside Drive, Ottawa, ON, K1H 7W9, CANADA, Ottawa, Canada
Background/Purpose: Joints with different sizes (e.g. small and large joints) and anatomical locations (upper and lower extremities) can be affected in psoriatic arthritis (PsA). Our…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].